Opioid therapy for chronic non-cancer pain: guidelines for Hong Kong

• Published in: Hong Kong medical journal = Xianggang yi xue za zhi Vol. 22; no. 5; pp. 496 - 505
• Main Authors: Cheung, C W, Chan, T Cw, Chen, P P, Chu, M C, Chui, W Cm, Ho, P T, Lam, F, Law, S W, Lee, J Ly, Wong, S Hs, Wong, V Kc
• Format: Journal Article
• Language: English; Chinese
• Published: China Hong Kong Academy of Medicine 01.10.2016
• Subjects: Addictions; Adult; Analgesics, Opioid - administration & dosage; Analgesics, Opioid - adverse effects; Cancer; Chronic pain; Chronic Pain - drug therapy; Dose-Response Relationship, Drug; Hong Kong; Humans; Informed Consent; Mental health; Morphine; Narcotics; Opioid-Related Disorders - prevention & control; Pain management; Patients; Physicians; Practice Guidelines as Topic; Substance abuse treatment; Surgery; Hong Kong China; China; Chronic pain/drug therapy; Practice guidelines as topic/standards; Analgesics, opioid/therapeutic use
• ISSN: 1024-2708; 2226-8707
• DOI: 10.12809/hkmj164920

Opioids are increasingly used to control chronic non-cancer pain globally. International opioid guidelines have been issued in many different countries but a similar document is not generally available in Hong Kong. Chronic opioid therapy has a role in multidisciplinary management of chronic non-cancer pain despite insufficient evidence for its effectiveness and safety for long-term use. This document reviews the current literature to inform Hong Kong practitioners about the rational use of chronic opioid therapy in chronic non-cancer pain. It also aims to provide useful recommendations for the appropriate, effective, and safe use of such therapy in the management of chronic non-cancer pain in adults. Physicians should conduct a comprehensive biopsychosocial evaluation of patients prior to the commencement of opioid therapy. When opioid use is deemed appropriate, the patient should provide informed consent within an agreement that specifies treatment goals and expectations. A trial of opioid can be commenced and, provided there is progress towards treatment goals, then chronic therapy can be considered at a dose that minimises harm. Monitoring of effectiveness, safety, and drug misuse should be continued. Treatment should be stopped when opioids become ineffective, intolerable, or misused. The driving principles for opioid prescription in chronic pain management should be: start with a low dose, titrate slowly, and maintain within the shortest possible time.